ContraFect is a clinical stage biotechnology company focused on discovering and developing therapeutic proteins and antibodies for life-threatening, drug-resistant infectious diseases, particularly those treated in hospital settings. The Company's most advanced product candidates are CF-301, a lysin for the treatment of Staph aureus bacteremia and CF-404, a cocktail of monoclonal antibodies for the treatment of life-threatening seasonal and pandemic varieties of influenza.
Type | Public | |
Founded | 2008 | |
HQ | Yonkers, NY, US | Map |
Website | contrafect.com | |
Employee Ratings | More |
USD | |
---|---|
Net income (Q2, 2020) | (17.6m) |
EBIT (Q2, 2020) | (8.2m) |
Market capitalization (1-Mar-2021) | 149.3m |
Closing stock price (1-Mar-2021) | 5.4 |
Cash (30-Jun-2020) | 30.8m |
EV | 122.3m |
USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
General and administrative expense | 1.2m | 2.3m | 2.3m | 2.9m | 2.4m | 4.7m | 2.5m | 1.9m | 2.1m | 2.3m | 1.8m | 2.2m | 2.1m | 2.3m | 2.6m | 2.4m | 3.0m | 2.6m |
R&D expense | 1.5m | 2.4m | 2.4m | 4.3m | 3.4m | 4.4m | 7.3m | 5.9m | 4.2m | 3.8m | 4.9m | 5.3m | 5.7m | 4.1m | 4.8m | 5.3m | 5.1m | 5.5m |
Operating expense total | 2.7m | 4.6m | 4.7m | 7.2m | 5.7m | 9.2m | 9.8m | 7.9m | 6.3m | 6.1m | 6.7m | 7.5m | 7.8m | 6.4m | 7.4m | 7.6m | 8.1m | 8.2m |
EBIT | (2.7m) | (4.6m) | (4.7m) | (7.2m) | (5.7m) | (9.2m) | (9.8m) | (7.9m) | (6.3m) | (6.1m) | (6.7m) | (7.5m) | (7.8m) | (6.4m) | (7.4m) | (7.6m) | (8.1m) | (8.2m) |
USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 2.2m | 31.3m | 12.4m | 23.6m | 20.8m | 7.6m | 10.6m | 10.7m | 4.7m | 4.9m | 4.3m | 4.6m | 11.0m | 6.8m | 7.4m | 10.5m | 10.6m | 30.8m |
Prepaid Expenses | 248.3k | 417.1k | 271.7k | 1.1m | 946.0k | 1.1m | 1.5m | 1.1m | 1.5m | 2.2m | 1.3m | 2.2m | 1.8m | 2.1m | 2.0m | 2.3m | 5.6m | 5.3m |
Current Assets | 2.4m | 31.7m | 23.2m | 36.3m | 30.4m | 27.4m | 20.6m | 44.4m | 30.3m | 23.9m | 53.8m | 35.5m | 39.4m | 25.1m | 16.2m | 12.8m | 22.3m | 45.0m |
PP&E | 2.5m | 2.3m | 2.0m | 1.9m | 1.7m | 1.5m | 1.5m | 1.3m | 1.2m | 1.2m | 1.1m | 1.1m | 1.1m | 1.2m | 1.2m | 1.1m | 1.1m | 1.0m |
USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (9.0m) | (25.4m) | (4.9m) | (12.0m) | (17.5m) | (8.9m) | (18.6m) | (29.1m) | (6.3m) | (9.2m) | (10.8m) | (39.2m) | (43.6m) | 11.6m | 2.9m | (2.4m) | (7.6m) | (25.2m) |
Depreciation and Amortization | 279.3k | 414.7k | 134.3k | 268.7k | 403.0k | 134.4k | 268.9k | 385.0k | 45.6k | 91.1k | 133.0k | 71.1k | 110.3k | 42.0k | 84.4k | 126.8k | 42.4k | 84.7k |
Accounts Payable | 490.0k | (1.6m) | (491.4k) | 559.7k | (420.2k) | 1.2m | 3.5m | 2.7m | 8.7k | (787.3k) | (1.5m) | 52.6k | 770.7k | (453.1k) | (2.5m) | 1.3m | (1.2m) | (4.2m) |
Cash From Operating Activities | (4.9m) | (11.0m) | (4.5m) | (10.4m) | (16.3m) | (6.5m) | (13.5m) | (21.3m) | (6.2m) | (13.2m) | (19.2m) | (13.2m) | (19.2m) | (7.3m) | (16.1m) | (19.8m) | (7.5m) | (17.7m) |
USD | Q2, 2014 |
---|---|
Debt/Equity | -0.2 x |
Debt/Assets | 1.5 x |
Financial Leverage | -0.1 x |
When was ContraFect founded?
ContraFect was founded in 2008.
Who are ContraFect key executives?
ContraFect's key executives are Roger J. Pomerantz, David N. Low and Michael J. Otto.
How many employees does ContraFect have?
ContraFect has 24 employees.
Who are ContraFect competitors?
Competitors of ContraFect include Xcell Biosciences, Abcam and TxCell.
Where is ContraFect headquarters?
ContraFect headquarters is located at 28 Wells Ave, Yonkers.
Where are ContraFect offices?
ContraFect has an office in Yonkers.
How many offices does ContraFect have?
ContraFect has 1 office.
Receive alerts for 300+ data fields across thousands of companies